Đang chuẩn bị liên kết để tải về tài liệu:
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Immune checkpoint inhibitors (ICI) either alone or in combination with chemotherapy have expanded our choice of agents for the palliative treatment of non-small cell lung cancer (NSCLC) patients. Unfortunately, not all patients will experience favorable response to treatment with ICI and may even suffer from severe side effects. |

TÀI LIỆU LIÊN QUAN

A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk

Báo cáo y học: "The anti-inflammatory effects of levocetirizine - are they clinically relevant or just an interesting additional effect"

Báo cáo khoa học: "Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma"

Báo cáo sinh học: " Exploring internal features of 16S rRNA gene for identification of clinically relevant species of the genus Streptococcus"

Báo cáo y học: " Rectal microbicides: clinically relevant approach to the design of rectal specific placebo formulations."

Complementary Medicine - A documentation of our clinically relevant research 1993 - 2010

A clinically relevant method to screen for hepatic steatosis in overweight adolescents: A cross sectional study

Is parenting style a predictor of suicide attempts in a representative sample of adolescents?

Risk factors for renal toxicity after inpatient cisplatin administration

Resistance profile of clinically relevant bacterial isolates against fluoroquinolone in Ethiopia: A systematic review and metaanalysis
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.